chlorprothixene and Leukemia, Myeloid, Acute

chlorprothixene has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Du, Y; Junaid, M; Kaushik, AC; Li, K; Wang, X; Wei, D	1

Other Studies

1 other study(ies) available for chlorprothixene and Leukemia, Myeloid, Acute

Article	Year
Identification of chlorprothixene as a potential drug that induces apoptosis and autophagic cell death in acute myeloid leukemia cells. The FEBS journal, 2020, Volume: 287, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Autophagic Cell Death; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Chlorprothixene; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Tumor Cells, Cultured	2020

Article

Year

Identification of chlorprothixene as a potential drug that induces apoptosis and autophagic cell death in acute myeloid leukemia cells.

The FEBS journal, 2020, Volume: 287, Issue:8

Topics: Antineoplastic Agents; Apoptosis; Autophagic Cell Death; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Chlorprothixene; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Tumor Cells, Cultured

2020